Sara Ghandehari, MD (IMAGE)
Caption
COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease. New research from Cedars-Sinai published online in the journal Chest supports this hypothesis.
Credit
Cedars-Sinai
Usage Restrictions
None
License
Licensed content